SLRNAcelyrin Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsNov 13
Mkt Cap$229.16M
Vol4.08M
News
all
press releases
News Placeholder
MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades
Wolfe Research compared MoonLake’s setback to Acelyrin’s HS trial failure, noting that Acelyrin’s stock never rebounded despite later progress in other programs.
Stocktwits
News Placeholder
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week
Investors on Stocktwits flocked to these five biotech stocks last week, ending Feb. 21, 2025, driven by buyout buzz, bullish analyst calls, and promising clinical developments.
Stocktwits
<
...
1
>

Advertisement|Remove ads.